Dr. Thorsen Wayne Haugen, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6429 Fax: 570-271-6854 |
Aileen Wertz, M.D. Otolaryngology - Pediatric Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6429 Fax: 570-271-6854 |
Dr. Jeremy Alexander Mock, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6429 Fax: 570-271-6854 |
Linda Gage-white, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6429 Fax: 570-271-6854 |
Jeff Wong, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6211 |
Dr. Joseph Scott Greene, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6429 |
James Barrese, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-214-5681 |
Dr. Carl L. Reams, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6429 |
Dr. Jennifer Renee Rager, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6429 Fax: 570-271-6854 |
Dr. Robert Tuliszewski Jr., M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6211 |
Kevin Stavrides, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6429 |
Dr. Kenneth Wayne Altman, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6429 Fax: 570-271-6854 |
Dr. Thomas L. Kennedy, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6429 |
Periakaruppan Manickam, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6114 |
Dr. Nicholas Craig Purdy, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6429 Fax: 570-271-6854 |
Dr. Arun K Gadre, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6429 Fax: 570-271-6854 |
Timothy Lynn Lindemann, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6429 |
James E Bland, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6429 Fax: 570-271-6854 |
Dr. William E. Wood, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6429 |
Lindsay Suzanne Eisler, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6211 |
News Archive
Like a motorist who knows that the "check engine" light indicates something important but ill-defined is happening, neuroscientists have relied heavily on an incompletely understood technology called functional magnetic resonance imaging to show them what the brain is doing when people respond to different stimuli.
Cedars-Sinai researchers have determined that two prevalent drug therapies - rifaximin and lubiprostone - offer some of the best options for treating irritable bowel syndrome, a widespread disorder that affects up to one in five Americans.
Lifestyle changes can play a considerable role in influencing the risk of developing cancer later in life. The key negative factors include smoking, lack of exercise and being overweight.
Incyte Corporation (Nasdaq: INCY) announced results from a 12-week, placebo-controlled, dose-escalationin involving 60 patients with active rheumatoid arthritis for its proprietary oral JAK1 inhibitor.
› Verified 8 days ago